JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2010, Vol. 48 ›› Issue (4): 45-.

• Articles • Previous Articles     Next Articles

Effect of 5-Aza-2′-deoxycytidine on SOCS-1 gene expression, proliferation and apoptosis in RPMI8226 cells

LU Fei, LIU Chuanfang, MA Daoxin, LIU Yanping,KONG Haili, ZHANG Jingjing   

  1. Department of Hematology,  Qilu Hospital of Shandong University, Jinan 250012, China
  • Received:2009-11-07 Online:2010-04-16 Published:2010-04-16

Abstract:

Objective  To investigate the effect of DNA methylation inhibitor 5-Aza-2′-deoxycytidine (5-Aza-CdR) on transcription regulation of SOCS-1 gene and the molecular biological behaviors in RPMI8226 cells. Methods  The RPMI8226 cells were treated with different doses of 5-Aza-CdR,  and MTT was used to detect the proliferation of RPMI8226 cells. The apoptosis and cell cycle were analyzed by flow cytometry.  Real-time PCR was used to examine expression of the SOCS-1 gene.  Results   5-Aza-CdR significantly inhibited  cell growth in dose and time dependent manners(P<0.05).5-Aza-CdR increased the apoptosis rate of RPMI8226 cells as well as  in a dose-dependent manner. The apoptosis rates of RPMI8226 cells treated with 5-Aza-CdR at concentration of 0.1,0.5,,1.0,2.0,5.0μmol/L for 72 hours were (29.62±2.87)%,(39.98±2.53)%,(49.07±3.51)%,(60.15±4.54)and(69.88±3.49)% respectively. After treatment with different concentrations of 5-Aza-CdR for 72h, cells were arrested in G (0)/G (1) phase in contrast to the control group (P<0.05).  Real-time PCR results showed that there were few SOCS-1 genes expressed in RPMI8226 cells after treatmean with 5-Aza-CdR for 72h,  and expression level of SOCS-1 was increased significantly in a concentration-dependent manner(P<0.05). Conclusion  5-Aza-CdR could narkedly inhibit the proliferation of RPMI8226 cells and induce cell apoptosis, which might be related to demethylation and reexpression of the SOCS-1 gene in RPMI8226 cells.

Key words:  DNA methylation; 5-Aza-2′-deoxycytidine; Suppressor of cytokine signaling 1; Multiple myeloma

CLC Number: 

  • R733.3
[1] PU Ye-di, LI Li-zhen, MA Dao-xin, DONG Ke,ZHAO Chuan-li, SONG Qiang, WANG Lu-qun. Establishment of a bortezomib-resistant cell line KM3/BTZ of human multiple myeloma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(2): 33-.
[2] LI Yin-zhu1, XU Wen-jun2, CUI Jing-ying2, REN Cui-ai2. The retrospective analysis of 53 patients with bisphosphonate-related osteonecrosis of the jaw [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(1): 109-112.
[3] ZHANG Jing-jing, MA Dao-xin, KONG Hai-li, WANG Hui-jun, SUN Yuan-xin, LIU Chuan-fang. AML1/ETO siRNA enhances the sensitivity of Kasumi-1 cells to  histone acetylation enzyme inhibitors [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(7): 68-73.
[4] ZHAO Ting,SONG Qiang, LI Li-zhen,WANG Lu-qun, ZHAO Chuan-li. Level of etythropoietin and expression of the etythropoietin  receptor in Myelodysplastic Syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(1): 67-70.
[5] LI Shan, LI Li-zhen, SONG Qiang, ZHAO Chuan-li, YAN Shu-xin, WANG Lu-qun. Effects of honokiol and Bortezomib on proliferation and  apoptosis in myeloma KM3 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(12): 32-36.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!